Healthcare | June 15, 2024
Fischer Medical Ventures and The Therapy Platform partner for mental healthcare
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
The collaboration aims to bolster healthcare entrepreneurship
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Connecting new production and consumption areas of chilled food by low-carbon transportation services
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Subscribe To Our Newsletter & Stay Updated
